Commentary on the HYPRESS Trial
icTV Interview with Todd Dorman
SCCM President Todd Dorman comments on the HYPRESS trial on the use of hydrocortisone for the prevention of septic shock. He highlights the strengths and limitations of this randomised controlled trial and notes several key considerations for future studies.
The results of this clinical trial were originally presented October 3rd during the President's Session at LIVES 2016 in Milan and simultaneously published in JAMA.
Link to the article in JAMA here.